Mitral Regurgitation Echocardiographic Evaluation in Patients with Implanted Devices

Patients with implanted devices and mitral regurgitation present a complex pathology, making accurately measuring the severity of the condition challenging. However, echocardiography remains essential for confirming the diagnosis, assessing the disease's severity, and predicting its prognosis. The decrease in mitral regurgitation parallels left ventricle reverse remodeling in CRT responders. Recent research showed a possible correlation between the right ventricle lead's position and mitral regurgitation severity in post-implantation patients. Updated guidelines recommend a comprehensive two-dimensional evaluation, including a detailed assessment of the mitral valve, the right ventricle, and the lead position. A systematic three-dimensional echocardiographic assessment of the mitral valve and surrounding structures should follow this approach. Three-dimensional echocardiographic software packages provide more detailed information about the etiology and severity of mitral regurgitation. Combining two-dimensional and three-dimensional echocardiographic evaluations will help better understand the condition, enabling treatment decisions. This promising development has the potential to improve patient outcomes significantly.